Market Access and Commercial Strategy

The Market Access and Commercial Strategy team at bluebird bio is responsible for developing and executing strategies to ensure patient access to innovative gene therapies for severe genetic diseases and cancer. This team collaborates across functions to navigate regulatory landscapes, engage healthcare providers, and demonstrate the value of gene therapies, ultimately driving the commercial success of bluebird bio's groundbreaking treatments.